| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.43.12.1440 |
| P698 | PubMed publication ID | 7958496 |
| P50 | author | Gerald Reaven | Q15488818 |
| P2093 | author name string | Chen YD | |
| Jeng CY | |||
| Sheu WH | |||
| Fuh MM | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Glucose | Q37525 |
| P304 | page(s) | 1440-1444 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. | |
| P478 | volume | 43 |
| Q46060318 | Altered fluxes responsible for reduced hepatic glucose production and gluconeogenesis by exogenous glucose in rats |
| Q42940455 | An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q44775968 | Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes |
| Q37358372 | Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs |
| Q34544816 | Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent |
| Q51270619 | Decreased basal hepatic glucose uptake in impaired fasting glucose. |
| Q35744039 | Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse |
| Q37205376 | Differences in insulin sensitivity and secretory capacity based on OGTT in subjects with impaired glucose regulation. |
| Q48510891 | Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? |
| Q37745200 | Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry |
| Q28555152 | Effect of Peripheral Electrical Stimulation (PES) on Nocturnal Blood Glucose in Type 2 Diabetes: A Randomized Crossover Pilot Study |
| Q51559853 | Ethnicity affects the postprandial regulation of glycogenolysis. |
| Q54511441 | Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect. |
| Q43512312 | Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus |
| Q58114787 | Glucose-Mediated Glucose Disposal at Baseline Insulin is Impaired in IFG |
| Q61443673 | Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway |
| Q34722593 | Hepatic glucose production: therapeutic target in type 2 diabetes? |
| Q34361034 | Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis |
| Q45949100 | Hepatic glucose-6-phosphatase flux and glucose phosphorylation, cycling, irreversible disposal, and net balance in vivo in rats. Measurement using the secreted glucuronate technique. |
| Q33760266 | Insulin resistance and antidiabetic drugs |
| Q35087577 | Is hepatic glucose production increased in type 2 diabetes mellitus? |
| Q35764871 | Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. |
| Q33833542 | MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. |
| Q22241286 | Mechanism by which metformin reduces glucose production in type 2 diabetes |
| Q93016700 | Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus |
| Q34143830 | Metabolic complications of obesity |
| Q22241437 | Metformin |
| Q37145443 | Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs |
| Q22241434 | Metformin: new understandings, new uses |
| Q91795538 | Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants |
| Q34370646 | Mitochondrial dysfunction and type 2 diabetes. |
| Q42460893 | Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes |
| Q30596447 | Quantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes |
| Q44129333 | S(G), S(I), and EGP of exercise-trained middle-aged men estimated by a two-compartment labeled minimal model |
| Q40521981 | The fourth musketeer--from Alexandre Dumas to Claude Bernard |
| Q46750674 | The relationship between peripheral glucose utilisation and insulin sensitivity in the regulation of hepatic glucose production: studies in normal and alloxan-diabetic dogs |
| Q35711925 | The role of the liver in type 2 diabetes |
| Q34635590 | Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers |
Search more.